ImmuPharma (LON:IMM) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened

ImmuPharma plc (LON:IMMGet Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.98 ($0.03) and traded as high as GBX 1.99 ($0.03). ImmuPharma shares last traded at GBX 1.96 ($0.03), with a volume of 259,624 shares changing hands.

ImmuPharma Stock Performance

The stock has a market cap of £8.06 million, a P/E ratio of -194.00 and a beta of 1.53. The stock’s fifty day moving average is GBX 1.68 and its 200 day moving average is GBX 1.98.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Stories

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.